You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 132 No. 7, July 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Transforming Growth Factor β3 (TGFβ3) Accelerates Wound Healing Without Alteration of Scar Prominence

Histologic and Competitive Reverse-Transcription–Polymerase Chain Reaction Studies

Liancun Wu, MD; Aamir Siddiqui, MD; David E. Morris, MD; David A. Cox, PhD; Sanford I. Roth, MD; Thomas A. Mustoe, MD

Arch Surg. 1997;132(7):753-760.


Abstract

Background
Transforming growth factor (TGF) β3 is a new isoform of the TGFβ superfamily and is presumed to play an important role in wound repair and scarring.

Objective
To examine the effects of TGFβ3 on wound healing and on reducing scarring.

Design and Interventions
Dermal ulcers were created on the ears of 75 anesthetized young female rabbits. Either TGFβ3 or vehicle was applied topically to the wounds. Wounds were bisected and analyzed histologically at postwounding day 7. A second group of wounds was treated with topical TGFβ3 and TGFβ2 or vehicle at days 0 and 3 and harvested at days 21 through 42 as an excessive scarring model. The third group of wounds was treated with TGFβ1, TGFβ2, and TGFβ3 and vehicle. The granulation tissue was harvested at day 7, and cellular RNA was extracted for performing competitive reverse-transcription polymerase chain reaction.

Main Outcome Measurement
The amount of new epithelium and granulation tissue was measured in TGFβ3- and vehicle-treated wounds. The hypertrophic index was calculated for scarring wounds treated with TGFβ2 and TGFβ3 or vehicle. Levels of TGFβ1 messenger RNA were measured in those wounds that were treated with TGFβ1, TGFβ2, and TGFβ3 and in their controls.

Results
The use of TGFβ3 (0.3-0.75) µg per wound) increased granulation tissue formation by more than 100% (P<.005). Epithelialization showed a biphase, either increasing 30% (P<.04) or decreasing 25% (P<.001) dependent on dose. No significant difference in the hypertrophic index was noted in TGFβ3-treated wounds compared with controls. Levels of TGFβ1 messenger RNA increased (7.1- to 14.9-fold) in those wounds treated with TGFβ2 compared with controls at day 7.

Conclusions
Exogenous TGFβ3 displays substantial vulnerary properties in wound healing and may be useful in treating nonhealing wounds. However, the observation that TGFβ3 can reduce scarring was not confirmed in this study, and the messenger RNA level in response to TGFβ3 suggests that it behaves similarly to TGFβ1.

Arch Surg. 1997;132:753-760



Author Affiliations

From the Division of Plastic and Reconstructive Surgery (Drs Wu, Siddiqui, Morris, and Mustoe) and Department of Pathology (Dr Roth), Northwestern University Medical School, Chicago, Ill, and the Pharmaceutical Division, Molecular Biology Resources, Ciba-Geigy Ltd, Basel, Switzerland (Dr Cox). Dr Siddiqui is now with the Division of Plastic and Reconstructive Surgery, University of Minnesota Medical School, Minneapolis, and Dr Morris is with the Department of Surgery, Henry Ford Hospital, Detroit, Mich.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Transforming growth factor {beta}1 signalling, wound healing and repair: a multifunctional cytokine with clinical implications for wound repair, a delicate balance
Klass et al.
Postgrad. Med. J. 2009;85:9-14.
ABSTRACT | FULL TEXT  

Avotermin: A Novel Antiscarring Agent
Durani et al.
INT J LOW EXTREM WOUNDS 2008;7:160-168.
ABSTRACT  

Calreticulin Enhances Porcine Wound Repair by Diverse Biological Effects
Nanney et al.
Am. J. Pathol. 2008;173:610-630.
ABSTRACT | FULL TEXT  

A "traffic control" role for TGF{beta}3: orchestrating dermal and epidermal cell motility during wound healing
Bandyopadhyay et al.
JCB 2006;172:1093-1105.
ABSTRACT | FULL TEXT  

Experimental Manipulation of Transforming Growth Factor-{beta} Isoforms Significantly Affects Adhesion Formation in a Murine Surgical Model
Gorvy et al.
Am. J. Pathol. 2005;167:1005-1019.
ABSTRACT | FULL TEXT  

Ontogenetic Transition in Fetal Wound Transforming Growth Factor-{beta} Regulation Correlates with Collagen Organization
Soo et al.
Am. J. Pathol. 2003;163:2459-2476.
ABSTRACT | FULL TEXT  

Differential expression of TGF-{beta}1 and TGF-{beta}3 in serosal tissues of human intraperitoneal organs and peritoneal adhesions
Chegini et al.
Hum Reprod 2001;16:1291-1300.
ABSTRACT | FULL TEXT  

Enhancement of Wound Healing by Hyperbaric Oxygen and Transforming Growth Factor {beta}3 in a New Chronic Wound Model in Aged Rabbits
Bonomo et al.
Arch Surg 2000;135:1148-1153.
ABSTRACT | FULL TEXT  

Transforming Growth Factor {beta}3 Promotes Fascial Wound Healing in a New Animal Model
Tyrone et al.
Arch Surg 2000;135:1154-1159.
ABSTRACT | FULL TEXT  

Transforming Growth Factor-ß1 Fails to Stimulate Wound Healing and Impairs Its Signal Transduction in an Aged Ischemic Ulcer Model : Importance of Oxygen and Age
Wu et al.
Am. J. Pathol. 1999;154:301-309.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.